Research Peptides

CJC-1295 DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone (GHRH) analog designed to stimulate the pituitary gland to release growth hormone. Unlike regular CJC-1295, the DAC modification extends the peptide's half-life, allowing for less frequent dosing while providing prolonged growth hormone secretion. This makes CJC-1295 DAC particularly effective in promoting muscle growth, fat loss, tissue repair, and improving overall recovery. It is commonly studied for its potential benefits in enhancing physical performance, supporting anti-aging, and improving body composition.

• Einzelheiten
• 1 Beiträge
• https://www.researchpeptides.co.uk/
• Andere
• 30-11--1
• Lebt in Vereinigtes Königreich (England)
• Wohnt in London